When did Piper Sandler initiate coverage on Danaher?

Coverage was initiated on June 11, 2026.

Why did Piper Sandler give a Neutral rating?

Analysts are waiting for new growth catalysts before becoming more bullish, describing their stance as 'feet in the shallow end'.

What is Piper Sandler's price target for Danaher?

The price target is $200 per share.

Piper Sandler Initiates Danaher (DHR) Coverage with Neutral Rating

Piper Sandler initiated coverage of Danaher Corporation (DHR) with a Neutral rating and $200 price target on June 11, as the firm launched coverage of the life science tools sector.

June 15, 2026

2 min read

Source: Insider Monkey

Key Numbers

price target

$200

Piper Sandler initiated coverage of Danaher Corporation (NYSE:DHR) with a Neutral rating and a $200 price target on June 11, as part of its launch of coverage on the life science tools sector.

Rating Change

Rating: Neutral
Price Target: $200
Previous Rating: N/A (initiation)

Analyst Rationale

Analysts at Piper Sandler described their approach as "feet in the shallow end," indicating a cautious stance while waiting for new growth catalysts before becoming more bullish. No specific catalysts were mentioned, but the firm noted near-term challenges in the life science tools space.

Context

Danaher was recently included in billionaire Larry Robbins' list of top 10 dividend stock picks. The stock currently trades around $190-200, making the price target close to current levels.

Conclusion

The Neutral rating reflects a cautious view on Danaher, with potential upside dependent on new growth drivers such as product innovation or improved demand for life science tools.

Frequently Asked Questions

Piper Sandler rated Danaher (DHR) as Neutral with a $200 price target.

Found this useful? Share it

This article was rewritten in Wrqti's editorial style based on information from the original source above. Content is informational only — not investment advice.